Showing 8431-8440 of 19301 results for "".
- The Impact of Yo-Yo Dieting on Kidney Health in Type 1 Diabetes Patientshttps://reachmd.com/news/the-impact-of-yo-yo-dieting-on-kidney-health-in-type-1-diabetes-patients/2471159/What's New New evidence links yo-yo dieting to an increased risk of kidney disease in patients with Type 1 diabetes, highlighting the importance of weight stability. Significance The findings underscore the need for healthcare professionals to guide
- Enhancing Glycemic Control: Momordica charantia as an Adjunctive Therapy in Type 2 Diabeteshttps://reachmd.com/news/enhancing-glycemic-control-momordica-charantia-as-an-adjunctive-therapy-in-type-2-diabetes/2485369/In a real-world cohort of adults with type 2 diabetes inadequately controlled on metformin, adding a standardized Momordica charantia extract to metformi
- Navigating the Dual Burden of Type 2 Diabetes: Financial Strain and Digital Solutionshttps://reachmd.com/news/navigating-the-dual-burden-of-type-2-diabetes-financial-strain-and-digital-solutions/2475908/Patients with type 2 diabetes confront a dual burden: the direct health consequences of abnormal blood glucose levels, such as hyperglycemia or hypoglycemia, and the substantial financial strain imposed by high drug and treatment costs. The financial impact of type 2 diabetes is evid
- Study Shows Reciprocal Relationship Between Asthma and Type 2 Diabeteshttps://reachmd.com/news/study-shows-reciprocal-relationship-between-asthma-and-type-2-diabetes/2468138/Individuals with type 2 diabetes (T2D) are more likely to develop asthma – and vice versa, according to an analysis of data on 17 million people being presented at the annual meeting of the European Association for the Study of Diabetes (EA
- Stress and the Onset of Type 2 Diabetes: New Insights for Clinicianshttps://reachmd.com/news/stress-and-the-onset-of-type-2-diabetes-new-insights-for-clinicians/2475335/Amid rising rates of type 2 diabetes, chronic stress and lifestyle pressures are emerging as underappreciated drivers of disease onset and progression. Clinicians screening at-risk populations must look beyond traditional markers to tu
- Enhancing Type 2 Diabetes Prediction Through Blood Metabolite Signatureshttps://reachmd.com/news/enhancing-type-2-diabetes-prediction-through-blood-metabolite-signatures/2485322/A pooled multi-cohort analysis identified a blood metabolite signature that improves type 2 diabetes prediction beyond traditional clinical ri
- Harnessing Wearable Technology: Enhancing Exercise Adherence in Type 2 Diabeteshttps://reachmd.com/news/harnessing-wearable-technology-enhancing-exercise-adherence-in-type-2-diabetes/2475166/Although low motivation often undermines exercise programs in type 2 diabetes, recent research shows that exercise adherence can improve significantly with
- CT Scans Can Predict Type 2 Diabetes Riskhttps://reachmd.com/news/ct-scans-can-predict-type-2-diabetes-risk/2467698/Analysis of CT scans in people who undergo imaging for health screening can identify individuals at risk of type 2 diabetes, according to a study published today in
- Overcoming Barriers in Adolescent Type 1 Diabetes Management: Integrating Combination Therapies and Digital Platformshttps://reachmd.com/news/overcoming-barriers-in-adolescent-type-1-diabetes-management-integrating-combination-therapies-and-digital-platforms/2475224/Adolescents with Type 1 Diabetes face persistent barriers to achieving durable glycemic control and avoiding sequelae such as diabetic nephropathy. Clinicians managing pediatric diabetes recognize that conventional insulin regimens may
- Innovative Pharmacologic Strategies for Preserving Beta-Cell Function in Type 1 Diabeteshttps://reachmd.com/news/innovative-pharmacologic-strategies-for-preserving-beta-cell-function-in-type-1-diabetes/2483462/Efforts to preserve beta-cell function in type 1 diabetes are accelerating as new pharmacologic strategies emerge, with early evidence suggesting meaningful clinical potential. Disruption of TXNIP-driven stress signaling and JAK/STAT immune pathways can accelerate beta-cell apoptosi